Immunogenicity and safety of a SARS-CoV-2 Inactivated Vaccine (KCONVAC) in healthy adults: Two randomized, double-blind, and placebo-controlled phase 1/2 clinical trials

Pan, H.; Liu, J.; Huang, B.; Li, G.; Chang, X.; Liu, Y.; Wang, W.; Chu, K.; Hu, J.; Li, J.; Zhu, D.; Wu, J.; Xu, X.; Zhang, L.; Wang, M.; Tan, W.; Huang, W.; Zhu, F.

Links

ORCID

Tools

Export citation

Search in Google Scholar

Immunogenicity and safety of a SARS-CoV-2 Inactivated Vaccine (KCONVAC) in healthy adults: Two randomized, double-blind, and placebo-controlled phase 1/2 clinical trials

Published in 2021 by H. Pan, J. Liu, B. Huang, G. Li, X. Chang, Y. Liu, W. Wang, K. Chu, J. Hu, J. Li, D. Zhu, J. Wu, X. Xu, L. Zhang, M. Wang and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload